Advertisement
Screener

SANGAMO THERAPEUTICS, INC. (SGMOQ) Scorecard

2.8 / 5 stars · 68/120 Roast Me

SANGAMO THERAPEUTICS, INC. (SGMOQ) Scorecard

  • 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
43/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q20/3 LoseSGMOQ / S&P
-80.00% / 15.20%
LoseSGMOQ / S&P
SGMOQ unavailable / 15.00%
LoseSGMOQ / S&P
SGMOQ unavailable / 50.40%
2026-Q10/3 LoseSGMOQ / S&P
-40.48% / -4.33%
LoseSGMOQ / S&P
-45.80% / 11.30%
LoseSGMOQ / S&P
-5.00% / 27.70%
2025-Q40/3 LoseSGMOQ / S&P
-37.31% / 2.65%
LoseSGMOQ / S&P
-31.57% / 9.00%
LoseSGMOQ / S&P
-16.98% / 13.40%
2025-Q31/3 WinSGMOQ / S&P
24.07% / 8.12%
LoseSGMOQ / S&P
-37.13% / 4.61%
LoseSGMOQ / S&P
-40.00% / 13.45%
2025-Q21/3 LoseSGMOQ / S&P
-18.18% / 10.94%
WinSGMOQ / S&P
565.52% / 4.83%
LoseSGMOQ / S&P
-78.26% / 10.63%
2025-Q11/3 LoseSGMOQ / S&P
-35.29% / -4.27%
WinSGMOQ / S&P
239.92% / 4.98%
LoseSGMOQ / S&P
-78.49% / 10.57%
2024-Q41/3 WinSGMOQ / S&P
17.24% / 2.41%
LoseSGMOQ / S&P
-67.20% / 5.25%
LoseSGMOQ / S&P
-63.95% / 6.15%
2024-Q31/3 WinSGMOQ / S&P
141.67% / 5.89%
LoseSGMOQ / S&P
-74.04% / 5.89%
LoseSGMOQ / S&P
-48.28% / 6.11%
2024-Q21/3 LoseSGMOQ / S&P
-46.27% / 4.28%
LoseSGMOQ / S&P
-94.38% / 5.38%
WinSGMOQ / S&P
15.00% / 5.12%
2024-Q12/3 WinSGMOQ / S&P
24.07% / 10.56%
LoseSGMOQ / S&P
-92.22% / 5.71%
WinSGMOQ / S&P
124.10% / 5.59%
2023-Q42/3 LoseSGMOQ / S&P
-10.00% / 11.69%
WinSGMOQ / S&P
58.34% / 6.81%
WinSGMOQ / S&P
17.60% / 7.78%
2023-Q32/3 LoseSGMOQ / S&P
-53.85% / -3.27%
WinSGMOQ / S&P
79.75% / 7.52%
WinSGMOQ / S&P
22.88% / -5.03%
2023-Q22/3 LoseSGMOQ / S&P
-26.14% / 8.74%
WinSGMOQ / S&P
91.39% / 9.50%
WinSGMOQ / S&P
2.56% / -8.57%
2023-Q11/3 LoseSGMOQ / S&P
-43.95% / 7.50%
WinSGMOQ / S&P
113.96% / 10.77%
LoseSGMOQ / S&P
-31.40% / -15.69%
2022-Q41/3 LoseSGMOQ / S&P
-35.92% / 7.56%
LoseSGMOQ / S&P
0.54% / 11.88%
WinSGMOQ / S&P
1.63% / -17.99%
2022-Q31/3 WinSGMOQ / S&P
18.36% / -4.88%
LoseSGMOQ / S&P
3.26% / 13.47%
LoseSGMOQ / S&P
-7.09% / -1.41%
2022-Q21/3 LoseSGMOQ / S&P
-28.74% / -16.10%
LoseSGMOQ / S&P
-17.11% / 13.71%
WinSGMOQ / S&P
23.16% / 11.04%
2022-Q10/3 LoseSGMOQ / S&P
-22.53% / -4.60%
LoseSGMOQ / S&P
-14.27% / 15.97%
LoseSGMOQ / S&P
37.50% / 42.23%
2021-Q40/3 LoseSGMOQ / S&P
-16.76% / 11.03%
LoseSGMOQ / S&P
-6.34% / 15.00%
LoseSGMOQ / S&P
SGMOQ unavailable / 96.40%
2021-Q30/3 LoseSGMOQ / S&P
-24.73% / 0.58%
LoseSGMOQ / S&P
-26.30% / 10.77%
LoseSGMOQ / S&P
SGMOQ unavailable / 69.42%
2021-Q21/3 LoseSGMOQ / S&P
-4.47% / 8.55%
WinSGMOQ / S&P
23.58% / 6.58%
LoseSGMOQ / S&P
SGMOQ unavailable / 51.81%
2021-Q11/3 LoseSGMOQ / S&P
-19.73% / 6.17%
WinSGMOQ / S&P
22.31% / -1.06%
LoseSGMOQ / S&P
SGMOQ unavailable / 7.39%
2020-Q42/3 WinSGMOQ / S&P
65.19% / 12.15%
WinSGMOQ / S&P
15.39% / -3.72%
LoseSGMOQ / S&P
SGMOQ unavailable / -33.42%
2020-Q31/3 LoseSGMOQ / S&P
5.47% / 8.93%
WinSGMOQ / S&P
97.87% / -2.04%
LoseSGMOQ / S&P
SGMOQ unavailable / -27.10%
2020-Q22/3 WinSGMOQ / S&P
40.66% / 20.54%
WinSGMOQ / S&P
46.59% / -0.46%
LoseSGMOQ / S&P
SGMOQ unavailable / -27.11%
2020-Q11/3 LoseSGMOQ / S&P
-23.89% / -19.60%
WinSGMOQ / S&P
34.48% / 3.47%
LoseSGMOQ / S&P
SGMOQ unavailable / -14.75%
2019-Q41/3 LoseSGMOQ / S&P
-7.51% / 9.07%
WinSGMOQ / S&P
21.29% / 5.36%
LoseSGMOQ / S&P
SGMOQ unavailable / 2.99%
2019-Q31/3 LoseSGMOQ / S&P
-15.97% / 1.70%
WinSGMOQ / S&P
5.27% / 5.02%
LoseSGMOQ / S&P
SGMOQ unavailable / 0.21%
2019-Q22/3 WinSGMOQ / S&P
12.89% / 4.30%
WinSGMOQ / S&P
28.97% / 6.64%
LoseSGMOQ / S&P
SGMOQ unavailable / 8.65%
2019-Q11/3 LoseSGMOQ / S&P
-16.90% / 13.65%
WinSGMOQ / S&P
74.50% / 8.12%
LoseSGMOQ / S&P
SGMOQ unavailable / 14.29%
2018-Q41/3 LoseSGMOQ / S&P
-32.27% / -13.52%
WinSGMOQ / S&P
130.95% / 9.05%
LoseSGMOQ / S&P
SGMOQ unavailable / 18.23%
2018-Q32/3 WinSGMOQ / S&P
19.37% / 7.71%
WinSGMOQ / S&P
118.10% / 10.21%
LoseSGMOQ / S&P
SGMOQ unavailable / 19.06%
2018-Q21/3 LoseSGMOQ / S&P
-25.26% / 3.43%
WinSGMOQ / S&P
151.64% / 9.03%
LoseSGMOQ / S&P
SGMOQ unavailable / 14.46%
2018-Q12/3 WinSGMOQ / S&P
15.85% / -0.76%
WinSGMOQ / S&P
142.58% / 7.68%
LoseSGMOQ / S&P
SGMOQ unavailable / 12.46%
2017-Q42/3 WinSGMOQ / S&P
9.33% / 6.64%
WinSGMOQ / S&P
88.60% / 7.03%
LoseSGMOQ / S&P
SGMOQ unavailable / 13.82%
2017-Q32/3 WinSGMOQ / S&P
70.45% / 4.48%
WinSGMOQ / S&P
65.47% / 5.68%
LoseSGMOQ / S&P
SGMOQ unavailable / 17.57%
2017-Q21/3 WinSGMOQ / S&P
69.23% / 3.09%
LoseSGMOQ / S&P
-7.54% / 4.83%
LoseSGMOQ / S&P
SGMOQ unavailable / 17.74%
2017-Q11/3 WinSGMOQ / S&P
70.49% / 6.07%
LoseSGMOQ / S&P
-37.07% / 3.67%
LoseSGMOQ / S&P
SGMOQ unavailable / 13.32%
2016-Q40/3 LoseSGMOQ / S&P
-34.13% / 3.82%
LoseSGMOQ / S&P
-50.96% / 2.09%
LoseSGMOQ / S&P
SGMOQ unavailable / 7.05%
2016-Q30/3 LoseSGMOQ / S&P
-20.03% / 3.85%
LoseSGMOQ / S&P
-56.83% / 0.20%
LoseSGMOQ / S&P
SGMOQ unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricSGMOQ total returnS&P 500 Total Return Index
Total return-71.15%20.78%
Annualized return-71.15%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricSGMOQ total returnS&P 500 Total Return Index
Total return-98.53%83.14%
Annualized return-57.01%12.86%

10Y · 2016-09-01 to 2026-08-27

MetricSGMOQ total returnS&P 500 Total Return Index
Total return-96.54%319.30%
Annualized return-28.56%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.